At Grann Pharmaceuticals, our commitment to rare disease begins with the patients and families who inspire our work. We collaborate with patient advocacy organizations, clinicians, and researchers to advance investigational mRNA therapies for Rett syndrome and other rare genetic conditions. Together, we aim to turn scientific progress into meaningful treatment possibilities for communities with significant unmet needs.